Pretreatment late-phase DCE-MRI predicts outcome in locally advanced cervix cancer

References

• Eifel PJ. Concurrent chemotherapy and radiation therapy as the standard of care for cervical cancer. Nat Clin Pract Oncol. 2006;3:248–255.
   PubMedGoogle Scholar
• Barbera L, Thomas G. Management of early and locally advanced cervical cancer. Semin Oncol. 2009;36:155–169.
   PubMed Web of Science ®Google Scholar
• Green JA, Kirwan JM, Tierney JF, et al. Survival and recurrence after concomitant chemotherapy and radiotherapy for cancer of the uterine cervix: a systematic review and meta-analysis. Lancet. 2001;358:781–786.
   PubMed Web of Science ®Google Scholar
• Klopp AH, Eifel PJ. Biological predictors of cervical cancer response to radiation therapy. Semin Radiat Oncol. 2012;22:143–150.
   PubMed Web of Science ®Google Scholar
• Höckel M, Knoop C, Schlenger K, et al. Intratumoral pO2 predicts survival in advanced cancer of the uterine cervix. Radiother Oncol. 1993;26:45–50.
   PubMed Web of Science ®Google Scholar
• Vaupel P, Mayer A. Hypoxia in cancer: significance and impact on clinical outcome. Cancer Metastasis Rev. 2007;26:225–239.
   PubMed Web of Science ®Google Scholar
• Barwick TD, Taylor A, Rockall A. Functional imaging to predict tumor response in locally advanced cervical cancer. Curr Oncol Rep. 2013;15:549–558.
   PubMed Web of Science ®Google Scholar
• Ellingsen C, Hompland T, Galappathi K, et al. DCE-MRI of the hypoxic fraction, radioresponsiveness, and metastatic propensity of cervical carcinoma xenografts. Radiother Oncol. 2014;110:335–341.
   PubMed Web of Science ®Google Scholar
• Cooper RA, Carrington BM, Loncaster JA, et al. Tumour oxygenation levels correlate with dynamic contrast-enhanced magnetic resonance imaging parameters in carcinoma of the cervix. Radiother Oncol. 2000;57:53–55.
   PubMed Web of Science ®Google Scholar
• Lyng H, Vorren AO, Sundfør K, et al. Assessment of tumor oxygenation in human cervical carcinoma by use of dynamic Gd-DTPA-enhanced MR imaging. J Magn Reson Imaging. 2001;14:750–756.
   PubMed Web of Science ®Google Scholar
• Zahra MA, Hollingsworth KG, Sala E, et al. Dynamic contrast-enhanced MRI as a predictor of tumour response to radiotherapy. Lancet Oncol. 2007;8:63–74.
   PubMed Web of Science ®Google Scholar
• Yuh WTC, Mayr NA, Jarjoura D, et al. Predicting control of primary tumor and survival by DCE MRI during early therapy in cervical cancer. Invest Radiol. 2009;44:343–350.
   PubMed Web of Science ®Google Scholar
• Yamashita Y, Baba T, Baba Y, et al. Dynamic contrast-enhanced MR imaging of uterine cervical cancer: pharmacokinetic analysis with histopathologic correlation and its importance in predicting the outcome of radiation therapy. Radiology. 2000;216:803–809.
   PubMed Web of Science ®Google Scholar
• Mannelli L, Patterson AJ, Zahra M, et al. Evaluation of nonenhancing tumor fraction assessed by dynamic contrast-enhanced MRI subtraction as a predictor of decrease in tumor volume in response to chemoradiotherapy in advanced cervical cancer. AJR Am J Roentgenol. 2010;195:524–527.
   PubMed Web of Science ®Google Scholar
• Semple SIK, Harry VN, Parkin DE, et al. A combined pharmacokinetic and radiologic assessment of dynamic contrast-enhanced magnetic resonance imaging predicts response to chemoradiation in locally advanced cervical cancer. Int J Radiat Oncol Biol Phys. 2009;75:611–617.
   PubMed Web of Science ®Google Scholar
• Andersen EKF, Hole KH, Lund KV, et al. Pharmacokinetic parameters derived from dynamic contrast enhanced MRI of cervical cancers predict chemoradiotherapy outcome. Radiother Oncol. 2013;107:117–122.
   PubMed Web of Science ®Google Scholar
• Hawighorst H, Weikel W, Knapstein PG, et al. Angiogenic activity of cervical carcinoma: assessment by functional magnetic resonance imaging-based parameters and a histomorphological approach in correlation with disease outcome. Clin Cancer Res. 1998;4:2305–2312.
   PubMed Web of Science ®Google Scholar
• Lund KV, Simonsen TG, Hompland T, et al. Short-term pretreatment DCE-MRI in prediction of outcome in locally advanced cervical cancer. Radiother Oncol. 2015;115:379–385.
   PubMed Web of Science ®Google Scholar
• Kolstad P. Intercapillary distance, oxygen tension and local recurrence in cervix cancer. Scand J Clin Lab Invest Suppl. 1968;106:145–157.
   PubMedGoogle Scholar
• Fyles AW, Milosevic M, Wong R, et al. Oxygenation predicts radiation response and survival in patients with cervix cancer. Radiother Oncol. 1998;48:149–156.
   PubMed Web of Science ®Google Scholar
• Sundfør K, Lyng H, Tropé CG, et al. Treatment outcome in advanced squamous cell carcinoma of the uterine cervix: relationships to pretreatment tumor oxygenation and vascularization. Radiother Oncol. 2000;54:101–107.
   PubMed Web of Science ®Google Scholar
• Nordsmark M, Loncaster J, Aquino-Parsons C, et al. The prognostic value of pimoni-dazole and tumour pO2 in human cervix carcinomas after radiation therapy: a prospective international multi-center study. Radiother Oncol. 2006;80:123–131.
   PubMed Web of Science ®Google Scholar
• Sundfør K, Lyng H, Rofstad EK. Tumour hypoxia and vascular density as predictors of metastasis in squamous cell carcinoma of the uterine cervix. Br J Cancer. 1998;78:822–827.
   PubMed Web of Science ®Google Scholar
• Pitson G, Fyles A, Milosevic M, et al. Tumor size and oxygenation are independent predictors of nodal diseases in patients with cervix cancer. Int J Radiat Oncol Biol Phys. 2001;51:699–703.
   PubMed Web of Science ®Google Scholar
• Höckel M, Schlenger K, Aral B, et al. Association between tumor hypoxia and malignant progression in advanced cancer of the uterine cervix. Cancer Res. 1996;56:4509–4515.
   PubMed Web of Science ®Google Scholar
• Fyles A, Milosevic M, Pintilie M, et al. Long-term performance of interstial fluid pressure and hypoxia as prognostic factors in cervix cancer. Radiother Oncol. 2006;80:132–137.
   PubMed Web of Science ®Google Scholar